WhileTP53 mutations were prevalent in both, CDKN2A and NOTCH1 mutations were more common in OSCC and PIK3CA mutations were higher in LSCC.These differences underscore the importance of site-specific molecular profiling to guide personalized treatment strategies and improveclinical outcomes in head and neck cancers. This evidence concerns the gene PIK3CA and head and neck cancer.